Akero Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results


SOUTH SAN FRANCISCO, Calif., March 17, 2023 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today reported fourth quarter and full year financial results for the period ending December 31, 2022.

Go here to read the rest:
Akero Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

Related Posts